Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Operating activities:
Net loss	$ (1,477,607)	$ (1,866,033)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	320,672	314,325
Amortization of capitalized software development costs	715,765	782,468
Amortization of intangible assets	325,446	337,230
Amortization of other deferred costs	61,184	59,362
Valuation adjustment for warrants liability	(39,403)	(1,266,464)
Share-based compensation expense	477,212	651,982
Other valuation adjustments	47,417	43,412
Loss on disposal of property and equipment	567	34,228
Provision for accounts receivable	71,907	80,086
Deferred tax benefit	0	(9,574)
Changes in assets and liabilities, net of effects of acquisitions:
Accounts and contract receivables	108,002	551,201
Other assets	(39,082)	346,036
Accounts payable	(567,503)	(536,076)
Accrued expenses	(279,881)	(117,157)
Deferred revenues	(2,183,705)	(463,777)
Net cash used in operating activities	(2,459,009)	(1,058,751)
Investing activities:
Purchases of property and equipment	(11,654)	(15,582)
Capitalization of software development costs	(497,988)	0
Net cash used in investing activities	(509,642)	(15,582)
Financing activities:
Principal repayments on term loan	(168,451)	(125,000)
Principal payments on capital lease obligation	(217,110)	(199,022)
Recovery of deferred financing costs	0	2,111
Proceeds from exercise of stock options and stock purchase plan	0	143,350
Payments related to settlement of employee shared-based awards	(11,702)	0
Net cash used in financing activities	(397,263)	(178,561)
Decrease in cash and cash equivalents	(3,365,914)	(1,252,894)
Cash and cash equivalents at beginning of period	9,882,136	6,522,600
Cash and cash equivalents at end of period	$ 6,516,222	$ 5,269,706